高血压中西医结合规范化诊疗路径专家共识

Expert consensus on standardized diagnosis and treatment pathway for hypertension with integrated traditional Chinese and Western medicine

  • 摘要: 《高血压中西医结合规范化诊疗路径专家共识》以“优势互补、标本兼治”为核心理念,系统整合中西医诊疗优势,构建标准化临床实践框架。共识基于循证医学证据与临床实践,针对不同分级高血压肝阳上亢证患者,提出阶梯化、个体化中西医结合治疗策略,重点规范了降压西药与中成药(如松龄血脉康胶囊、天麻钩藤颗粒及养血清脑颗粒)的协同应用方案。其核心价值在于推动高血压治疗从单纯血压控制向症状改善、靶器官保护及生活质量提升的综合管理转变,形成可操作、规范化的中西医结合诊疗体系,为临床实践提供科学、权威的参考依据。

     

    Abstract: Expert Consensus on Standardized Diagnosis and Treatment Pathway for Hypertension with Integrated Traditional Chinese and Western Medicine takes "complementary advantages, treating both the root cause and symptoms" as its core philosophy. It systematically integrates the diagnostic and therapeutic strengths of traditional Chinese medicine (TCM) and Western medicine, and establishes a standardized clinical practice framework. Based on evidence-based medical evidence and clinical practice, targeting patients with hypertension of different grades presenting with hyperactivity of liver yang syndrome, the Consensus proposes a stepped and individualized integrated traditional Chinese and Western medicine treatment strategy, with a focus on standardizing the synergistic application plan of Western antihypertensive drugs and Chinese patent medicines (such as Songling Xuemaikang Capsules, Tianma Gouteng Granules, and Yangxue Qingnao Granules). Its core value lies in promoting the transformation of hypertension treatment from simple blood pressure control to comprehensive management that encompasses symptom improvement, target organ protection, and quality of life enhancement. It forms an operable and standardized integrated TCM-Western medicine diagnosis and treatment system, providing a scientific and authoritative reference for clinical practice.

     

/

返回文章
返回